Hodson R C, Schiff J A, Mather J P
Department of Biology, Brandeis University, Waltham, Massachusetts 02154.
Plant Physiol. 1971 Feb;47(2):306-11. doi: 10.1104/pp.47.2.306.
Seven mutants of Chlorella pyrenoidosa (Emerson strain 3) impaired for sulfate utilization have been isolated after treatment of the wild-type organism with nitrosoguanidine by replica plating on media containing thiosulfate and l-methionine. These mutants fall into three classes based on their ability to grow on sulfate, accumulate compounds labeled from sulfate-(35)S, and reduce adenosine 3'-phosphate 5'-phosphosulfate-(35)S (PAPS-(35)S) to thiosulfate-(35)S. Mutant Sat(2) (-) cannot grow on sulfate, but it accumulates thiosulfate-(35)S and homocysteic acid-(35)S from sulfate-(35)S in vivo. In addition, extracts of mutant Sat(2) (-) reduce PAPS-(35)S to thiosulfate-(35)S, indicating the possession of enzyme fractions S and A, both of which are required for thiosulfate formation. Mutants Sat(1) (-), Sat(3) (-), Sat(4) (-), Sat(5) (-), and Sat(6) (-) cannot grow on sulfate, and their extracts lack the ability to reduce PAPS-(35)S to thiosulfate-(35)S. Mutant Sat(7) (-)R(1), a probable revertant, can grow on sulfate but still lacks the ability to reduce PAPS-(35)S to thiosulfate-(35)S in vitro. Complementation experiments in vitro show that the block in formation of acid-volatile radioactivity in every case is due to the absence of activity associated with fraction S. All mutants can grow on thiosulfate and all possess the activating enzymes which convert sulfate to PAPS. Through a comparison of nutritional and enzymatic characteristics, the first outlines of a branched and complicated pathway for sulfate reduction in Chlorella are beginning to emerge.
在用亚硝基胍处理野生型小球藻(艾默生3号菌株)后,通过在含有硫代硫酸盐和L-甲硫氨酸的培养基上进行影印接种,分离出了7株利用硫酸盐能力受损的小球藻突变体。根据这些突变体在硫酸盐上生长的能力、积累由硫酸盐 - (35)S标记的化合物的能力以及将腺苷3'-磷酸5'-磷酸硫酸酯 - (35)S(PAPS - (35)S)还原为硫代硫酸盐 - (35)S的能力,这些突变体可分为三类。突变体Sat(2) (-)不能在硫酸盐上生长,但它在体内能从硫酸盐 - (35)S积累硫代硫酸盐 - (35)S和高半胱氨酸 - (35)S。此外,突变体Sat(2) (-)的提取物能将PAPS - (35)S还原为硫代硫酸盐 - (35)S,表明其具有形成硫代硫酸盐所需的酶组分S和A。突变体Sat(1) (-)、Sat(3) (-)、Sat(4) (-)、Sat(5) (-)和Sat(6) (-)不能在硫酸盐上生长,并且它们的提取物缺乏将PAPS - (35)S还原为硫代硫酸盐 - (35)S的能力。突变体Sat(7) (-)R(1)可能是回复突变体,能在硫酸盐上生长,但在体外仍缺乏将PAPS - (35)S还原为硫代硫酸盐 - (35)S的能力。体外互补实验表明,在每种情况下,酸性挥发性放射性物质形成的阻断都是由于缺乏与组分S相关的活性。所有突变体都能在硫代硫酸盐上生长,并且都具有将硫酸盐转化为PAPS的激活酶。通过对营养和酶学特性的比较,小球藻中硫酸盐还原的一条分支且复杂的途径的初步轮廓开始显现。